Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34540819)
Watch
English
Mifepristone: bioavailability, pharmacokinetics and use-effectiveness
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
11858883
retrieved
2 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Mifepristone: bioavailability, pharmacokinetics and use-effectiveness
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11858883
retrieved
2 August 2017
main subject
pharmacokinetics
1 reference
based on heuristic
inferred from title
mifepristone
1 reference
based on heuristic
inferred from title
bioavailability
1 reference
based on heuristic
inferred from title
author name string
Sarkar NN
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11858883
retrieved
2 August 2017
publication date
1 March 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
11858883
retrieved
2 August 2017
published in
European Journal of Obstetrics Gynecology and Reproductive Biology
1 reference
stated in
Europe PubMed Central
PubMed ID
11858883
retrieved
2 August 2017
volume
101
1 reference
stated in
Europe PubMed Central
PubMed ID
11858883
retrieved
2 August 2017
issue
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11858883
retrieved
2 August 2017
page(s)
113-120
1 reference
stated in
Europe PubMed Central
PubMed ID
11858883
retrieved
2 August 2017
cites work
Clinical pharmacology of RU 486--an antiprogestin and antiglucocorticoid
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mifepristone and first trimester abortion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mifepristone: clinical pharmacology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacodynamics of the antiprogesterone RU486 in women after oral administration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of the antiprogesterone RU 486 in women during multiple dose administration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitation of RU 486 in human plasma by HPLC and RIA after column chromatography
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Determination of RU486 (mifepristone) in blood by radioreceptorassay; a pharmacokinetic study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mifepristone: antineoplastic studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Distribution of RU 486 and its demethylated metabolites in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Plasma concentrations and receptor binding of RU 486 and its metabolites in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of mifepristone after low oral doses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-response relationships of RU 486.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetic study of orally administered RU 486 in non-pregnant women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Levels of the antiprogestin RU 486 and its metabolites in human blood and follicular fluid following oral administration of a single dose
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical Pharmacokinetics of Mifepristone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Progesterone receptors: expression and regulation in the mammalian ovary
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Atomic structure of progesterone complexed with its receptor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular mechanisms of action of steroid/thyroid receptor superfamily members
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A single amino acid that determines the sensitivity of progesterone receptors to RU486.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RU486: the French experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study--final results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pregnancy termination with mifepristone and gemeprost: a multicenter comparison between repeated doses and a single dose of mifepristone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05--a multicentre randomized clinical trial in China
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Termination of early human pregnancy with either 50 mg or 200 mg single oral dose of mifepristone (RU486) in combination with either 0.5 mg or 1.0 mg vaginal gemeprost
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Blood loss in termination of early pregnancy with mifepristone and gemeprost
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Blood loss with mifepristone--misoprostol abortion: measures from a trial in China, Cuba and India
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Side effects of mifepristone-misoprostol abortion versus surgical abortion. Data from a trial in China, Cuba, and India
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early pregnancy termination with mifepristone and misoprostol in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interruption of early pregnancy with mifepristone in combination with gemeprost
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An effective regimen for early medical abortion: a report of 2000 consecutive cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose mifepristone 200 mg and vaginal misoprostol for abortion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The efficacy of medical abortion: a meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Misoprostol for medical evacuation of early pregnancy failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison between oral and vaginal administration of misoprostol on uterine contractility
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Absorption kinetics of misoprostol with oral or vaginal administration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of the antiprogesterone RU 486: no correlation to clinical performance of RU 486
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hormonal anti-implantation agents: antiprogestins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Contraception with anti-progesterone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of low weekly doses of mifepristone on ovarian function and endometrial development
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of low daily doses of mifepristone on ovarian function and endometrial development
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of once weekly administration of mifepristone on ovarian function in normal women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of long-term low-dose mifepristone on reproductive function in women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Contraceptive efficacy of low doses of mifepristone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early luteal phase treatment with mifepristone (RU 486) for fertility regulation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Contraceptive use of antiprogestin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900522-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0301-2115(01)00522-X
1 reference
stated in
Europe PubMed Central
PubMed ID
11858883
retrieved
2 August 2017
PubMed ID
11858883
1 reference
stated in
Europe PubMed Central
PubMed ID
11858883
retrieved
2 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
